English
Chinese
Cart
We are a leading provider of innovative, high-quality injectable solutions and services committed to improving health for patients worldwide.
Our teams around the globe have been playing a vital role in the race to deliver an effective vaccine for COVID-19 working by the side of our customers to improve patient health.
With almost 10,000 team members across 50 sites worldwide, we help support our customers by delivering over 40 billion components and devices each year.
As a trusted partner to established and emerging drug developers, we help ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients.
Integrated Solutions
Knowledge Center
Online Store
Announcements
NovaGuard® SA Pro Safety System Award
West's NovaGuard® SA Pro safety system won the INTERPHEX Global Best Technologies Innovation Award
DeltaCube™ Modeling Platform
West’s DeltaCube™ Modeling Platform is an online, subscription-based modeling tool that provides customers with a data-driven approach to guide vial, stopper, and seal combination selection.
NovaGuard® SA Pro Safety System Award
West's NovaGuard® SA Pro safety system won the INTERPHEX Global Best Technologies Innovation Award
DeltaCube™ Modeling Platform
West’s DeltaCube™ Modeling Platform is an online, subscription-based modeling tool that provides customers with a data-driven approach to guide vial, stopper, and seal combination selection.
Our Products
West products promote the efficiency, reliability and safety of the world's pharmaceutical drug supply.
Company Background
Our company is the leading global manufacturer in the design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable medicines. We are a trusted partner to the world's top pharmaceutical and biotechnology companies–working by their side to improve patient health.
Our Culture of Giving
Nurturing a culture of philanthropy and community involvement is one of the defining characteristics of our company.
Careers
Come join a diverse, close-knit community of professionals, where everyone has a voice and opportunity to learn and grow through mutual trust and respect. Learn how you can join us and help us to create value for our customers and patients, our community, and our team members.
Featured Blogs
December 01, 2021
Selecting a Vial Container Closure System with the DeltaCube™ Modeling Platform
The pharmaceutical and biotech industries face many challenges when selecting the appropriate stopper, seal, and vial combination for a drug product. Further compounding these challenges is the manufacturing capability of each component supplier. Lot to lot variation can result in components that had maintained container closure integrity (CCI) and visual acceptance during development unexpectedly failing during production. Therefore, it is important to take a system approach when selecting vial container closure system (CCS) components and designing a fill-finish process. To minimize the risk for sterility failure and maximize performance, it is essential to understand not just the process, but also the historical and trending performance of the selected parenteral packaging components. As a result, West has built the DeltaCube™ Modeling Platform to facilitate data-driven selection and optimization of vial CCS components.
November 17, 2021
Regulatory guidance on particulate matter in injectable drugs
Regulatory and market expectations constantly increase. Novel drug products such as cell and gene therapies have a very high value and therefore each dose is precious. With that, drug product manufacturers face increased pressure to minimize rejects of finished drug products. One aspect of this is controlling particulate matter. Particulate matter in finished drug products can come from a number of sources, including the ingredients in the drug product, manufacturing equipment and environment, or the components of the container closure system. This blog describes approaches to control and measure particulate matter.
November 11, 2021
Using Hansen Solubility Parameters to predict excipient impacts on drug packaging and delivery devices
The drug and packaging industries have always been extremely conscientious to ensure that anything added to a delivery device to improve performance (e.g., silicone oil used to coat the inner surface of a syringe barrel), does not affect a drug’s efficacy or safety. But what about the converse? How do we make sure that the drug, or more specifically its added excipients, does not affect the delivery system’s performance? The term excipient refers to any member of a broad group of surfactants, preservatives, tonicity agents, and buffers which formulation scientists take great care to balance in order to provide the drug, such as a therapeutic protein, in its most effective and deliverable state.
December 01, 2021
Selecting a Vial Container Closure System with the DeltaCube™ Modeling Platform
The pharmaceutical and biotech industries face many challenges when selecting the appropriate stopper, seal, and vial combination for a drug product. Further compounding these challenges is the manufacturing capability of each component supplier. Lot to lot variation can result in components that had maintained container closure integrity (CCI) and visual acceptance during development unexpectedly failing during production. Therefore, it is important to take a system approach when selecting vial container closure system (CCS) components and designing a fill-finish process. To minimize the risk for sterility failure and maximize performance, it is essential to understand not just the process, but also the historical and trending performance of the selected parenteral packaging components. As a result, West has built the DeltaCube™ Modeling Platform to facilitate data-driven selection and optimization of vial CCS components.
November 17, 2021
Regulatory guidance on particulate matter in injectable drugs
Regulatory and market expectations constantly increase. Novel drug products such as cell and gene therapies have a very high value and therefore each dose is precious. With that, drug product manufacturers face increased pressure to minimize rejects of finished drug products. One aspect of this is controlling particulate matter. Particulate matter in finished drug products can come from a number of sources, including the ingredients in the drug product, manufacturing equipment and environment, or the components of the container closure system. This blog describes approaches to control and measure particulate matter.
November 11, 2021
Using Hansen Solubility Parameters to predict excipient impacts on drug packaging and delivery devices
The drug and packaging industries have always been extremely conscientious to ensure that anything added to a delivery device to improve performance (e.g., silicone oil used to coat the inner surface of a syringe barrel), does not affect a drug’s efficacy or safety. But what about the converse? How do we make sure that the drug, or more specifically its added excipients, does not affect the delivery system’s performance? The term excipient refers to any member of a broad group of surfactants, preservatives, tonicity agents, and buffers which formulation scientists take great care to balance in order to provide the drug, such as a therapeutic protein, in its most effective and deliverable state.